You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 31 - 40 of 632 results
 
  • Record 1 TO 632

  1. ANTIHIV INTERBODIES FOR GENE THERAPY IN CD4+ CELLS

    SBC: Virus Research Institute            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  2. Anti-inflammatory Drug Discovery Using DictyoSuitelium

    SBC: Leukosite, Inc.            Topic: N/A

    As critical components of cell-mediated immunity, chemokine and chemokine receptors play pivotal roleukocyte migration and cell adhesion. A long term objective is to discover and develop small molecucan block the binding of chemokine to its receptor or the downstream signaling pathways, and therebyan essential step in the inflammation process. DictyoSuitelium is a simple eukaryote that exhibits wr ...

    SBIR Phase I 1995 Department of Health and Human Services

  3. ANTIRETROVIAL DNA VACCINE

    SBC: CAMBRIDGE SCIENTIFIC, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

  4. ANTITHROMBOTIC TISSUE SOLDER FOR MICROVASCULAR REPAIRS

    SBC: ABIOMED, INC.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  5. AN YTTRIUM ALUMINUM PEROVSKITE BASED GAMMA-RAY DOSIMETER

    SBC: W Peter Trower Inc.            Topic: N/A

    N/A

    SBIR Phase I 1994 Nuclear Regulatory Commission

  6. A PERFUSION TEST FOR DETECTING THE AGENT OF LYME DISEASE

    SBC: IMMUNETICS, INC.            Topic: N/A

    THE OBJECTIVE OF THE WORK IS TO DETERMINE WHETHER A NOVEL PROPRIETARY DEVICE DESIGNED TO DETECT ACTIVE LYME DISEASE SPIROCHETAL INFECTION CAN BE EXPLOITED COMMERCIALLY. THIS DEVICE IS INTENDED TO PERFUSE THE SKIN OF A PATIENT AND AUTOMATICALLY DELIVER THE SAMPLE INTO A VESSEL CONTAINING CULTURE MEDIUM. IN PHASE I OF THIS PROJECT, VARIOUS PROTOTYPE MODELS OF THE PERFUSION DEVICE WILL BE CONSTRUCTED ...

    SBIR Phase I 1991 Department of Health and Human Services

  7. A PERFUSION TEST FOR DETECTING THE AGENT OF LYME DISEASE

    SBC: IMMUNETICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1991 Department of Health and Human Services

  8. ARC DETECTION FOR AMPLIFICATION BASED GENETIC TYPING

    SBC: Mosaic Technologies, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  9. 1-800-ASI-Help an Instrument Hotline

    SBC: Modern Psychiatric Systems,            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services

  10. ASSAY TO RAPIDLY DETECT ENDOTOXIN IN WHOLE BLOOD

    SBC: Cytosignet, Inc            Topic: N/A

    THE OBJECTIVE OF THIS RESEARCH IS TO PROVIDE THE FIRST RAPID AND RELIABLE ASSAY FOR DETECTING ENDOTOXIN (LIPOPOLYSACCHARIDES FROM GRAM-NEGATIVE BACTERIA) IN WHOLE BLOOD SAMPLES. THE ASSAY EMPLOYS A VERY SENSITIVE AGGLUTINATION INHIBITION METHODOLOGY. THE RED BLOOD CELLS PRESENT IN NORMAL, ENDOTOXIN NEGATIVE, WHOLE BLOOD SAMPLES AGGLUTINATE IN THE TEST WITHIN 60 SECONDS. SAMPLES FROM PATIENTS SUFFE ...

    SBIR Phase I 1991 Department of Health and Human Services
US Flag An Official Website of the United States Government